Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02719574
Title Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Forma Therapeutics, Inc.
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Cytarabine + Olutasidenib

Olutasidenib

Azacitidine + Olutasidenib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

Additional content available in CKB BOOST